Zydus Wellness Limited (NSE:ZYDUSWELL) has scheduled a conference call with analysts and institutional investors for 3:00 p.m. IST on Tuesday, August 4, 2026, immediately following the announcement of its unaudited financial results for the quarter ended June 30, 2026. The company disclosed the call schedule on July 21, 2026, in compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30.
Key Highlights
- Zydus Wellness has scheduled a Q1FY27 results conference call for August 4, 2026, at 3:00 p.m. IST, to be held post announcement of unaudited financial results for the quarter ended June 30, 2026.
- The call will be represented by Mr. Tarun Arora, Chief Executive Officer, and Mr. Umesh Parikh, Chief Financial Officer of Zydus Wellness.
- The conference call is open to analysts and institutional investors through multiple access channels, including universal access dial-in numbers and toll-free numbers for Singapore, Hong Kong, UK, and USA.
- Participants can register using the Diamond Pass registration link provided by the company for seamless access to the call.
- The announcement was filed with both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- ICICI Securities has been appointed as the call coordinator, with designated contacts for investor queries and clarifications.
About the Company
Zydus Wellness Limited (NSE:ZYDUSWELL; BSE:531335) is a leading consumer wellness company headquartered in India. The company operates through a diversified portfolio of brands spanning nutrition, digestive health, personal care, and wellness segments. Zydus Wellness is listed on both the National Stock Exchange of India and BSE Limited. The company serves the domestic and select international markets through a combination of direct-to-consumer channels, modern trade, and traditional retail distribution. The organisation maintains manufacturing facilities across India to support its product portfolio and supply chain operations.
Announcement in Detail
Zydus Wellness has formally notified market participants through a filing dated July 21, 2026, that the company will conduct a conference call on Tuesday, August 4, 2026, at 3:00 p.m. IST. This call is scheduled to take place immediately following the announcement of the company's unaudited financial results for the first quarter of financial year 2027, ending June 30, 2026. The notification has been filed with both stock exchange authorities in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, which mandates timely disclosure of material corporate events to listed company shareholders and market participants.
The conference call will feature senior management representation including Mr. Tarun Arora, who serves as Chief Executive Officer, and Mr. Umesh Parikh, who holds the position of Chief Financial Officer. These executives will address analyst and institutional investor participants on matters pertaining to the company's quarterly financial performance, operational developments, and business outlook. The call is accessible through multiple channels: universal access dial-in numbers for India, namely +91 22 6280 1144 and +91 22 7115 8045, as well as dedicated toll-free numbers for international participants in Singapore (8001012045), Hong Kong (800964448), United Kingdom (08081011573), and United States (18667462133). Participants wishing to join via the Diamond Pass registration platform may access the dedicated registration link provided by the company.
ICICI Securities Limited has been appointed as the call coordinator. The lead coordinators are Mr. Jaideep Goswami, Head of Equities, Mr. Manoj Menon, Head of Research, and Mr. Akshay Krishnan, who will facilitate the session. Mr. Rushad Kapadia serves as the designated contact for any clarifications or technical queries. Contact details including email addresses and direct telephone lines have been disclosed to enable investors to connect with the coordinating team ahead of the conference call.
Impact on Investors
Investors will note that the scheduled conference call represents a formal channel through which management will address questions and provide commentary on the company's financial performance for Q1FY27 immediately following the public announcement of results. This investor interaction mechanism allows shareholders and market participants to seek clarification on quarterly performance metrics, business segment trends, and management guidance in real time. The timing of the call, scheduled for the same day as the results announcement post market close, enables investors to obtain direct management perspective on reported figures without delays.
The availability of multiple dial-in access points and digital registration options facilitates participation by both domestic and international institutional investors, potentially broadening the pool of market participants who can engage with company management. Investors attending the call should have reviewed the official financial results filing prior to participation. The disclosed names and contact details of company representatives and call coordinators ensure that shareholders seeking further information or facing technical difficulties have direct escalation pathways. The filing demonstrates compliance with mandatory disclosure requirements, confirming that the company has formally notified all market infrastructure institutions and participants of the scheduled investor interaction event.
Sector / Market Context
India's consumer wellness and nutrition sector has witnessed steady growth as consumers increasingly invest in preventive health and wellness products. The sector encompasses dietary supplements, nutraceuticals, digestive health products, and personal care items, serving both urban and emerging consumer demographics. Listed companies in the wellness space routinely conduct analyst calls following quarterly results to maintain transparency with institutional investors and market analysts, a practice aligned with SEBI disclosure norms and investor relations best practices. Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements mandates that all material events, including scheduled investor interactions, be disclosed promptly to maintain market integrity and ensure equal access to information among all stakeholder categories.